$AXGN

$37.46 +$0.00 (0.0%) After hours

$AXGN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$AXGN Management Team

Mr. Paul Thomas

Independent Chairman of the Board

Age 69

Compensation $253.1K USD

Sex Male

Mr. Michael Dale

President

Chief Executive Officer

Director

Age 65

Compensation $8.848M USD

Sex Male

Ms. Lindsey Hartley

Chief Financial Officer

Age -

Compensation -

Sex Female

Mr. Marc Began

Executive Vice President

Chief Compliance Officer

General Counsel

Age 58

Compensation $1.848M USD

Sex Male

Mr. Jens Kemp

Chief Marketing Officer

Age 48

Compensation $1.746M USD

Sex Male

Mr. Rick Ditto

Vice President - Global Health Economics

Reimbursement & Policy

Age -

Compensation -

Sex Male

Mr. Erick Devinney

Chief Innovation Officer

Age 49

Compensation $2.267M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Paul Thomas Independent Chairman of the Board	69	$253.1K USD	Male
Mr. Michael Dale President Chief Executive Officer Director	65	$8.848M USD	Male
Ms. Lindsey Hartley Chief Financial Officer	-	-	Female
Mr. Marc Began Executive Vice President Chief Compliance Officer General Counsel	58	$1.848M USD	Male
Mr. Jens Kemp Chief Marketing Officer	48	$1.746M USD	Male
Mr. Rick Ditto Vice President - Global Health Economics Reimbursement & Policy	-	-	Male
Mr. Erick Devinney Chief Innovation Officer	49	$2.267M USD	Male

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

serving now

Independent

7 of 8

stated in the proxy

Average tenure

5.1 years

from year joined

CEO also chairs the board

Paul Thomas

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Paul Thomas Board chair	70	2020 6 years	Independent	None stated	None stated	$242,055
Michael Dale CEO	66	2024 2 years	Not independent	None stated	BiomimedX, Inc.	Paid as CEO
William Burke	57	2022 4 years	Independent	None stated	None stated	$224,990
John H. Johnson	68	2021 5 years	Independent	None stated	Verastem Oncology	$217,490
Alan M. Levine	58	2019 7 years	Independent	None stated	None stated	$217,490
Joseph Tyndall	57	2022 4 years	Independent	None stated	None stated	$209,990
Kathy Weiler	56	2023 3 years	Independent	None stated	None stated	$212,655
Amy Wendell	65	2016 10 years	Independent	None stated	Hologic, Inc.	$224,990

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 29, 2026

Global Nerve Foundation ("GNF")

a related party; certain executives of the Company are members of GNF's board of directors

$100,000

year ended December 31, 2025

Company contributions to GNF during 2025

Open in proxy

Global Nerve Foundation ("GNF")

a related party; certain executives of the Company are members of GNF's board of directors

A total amount not to exceed $100,000

July 20, 2024 to December 31, 2031

Qualified Founding Partner Agreement with GNF granting the Company benefits related to GNF's programming and marketing, entered July 20, 2024 and terminating December 31, 2031; early termination requires payments of the next two scheduled payments

Open in proxy

Comments

Company Executives

$AXGN Management Team

Mr. Paul Thomas

Mr. Michael Dale

Ms. Lindsey Hartley

Mr. Marc Began

Mr. Jens Kemp

Mr. Rick Ditto

Mr. Erick Devinney

Board of Directors

Related-party transactions